{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:54:04Z","timestamp":1791399244949,"version":"4.3.3"},"reference-count":56,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Background: Lipedema is a chronic disease of subcutaneous adipose tissue that predominantly affects women and is frequently associated with endocrinopathies such as insulin resistance and obesity. Its pathogenesis is still unclear, and treatment, which requires a multi-disciplinary approach, is prolonged over time and is not always effective. There is currently no drug treatment available for this disease. Methods: Five different cases of women with lipedema and insulin resistance, treated with Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and once-weekly exenatide, in association or not with lifestyle changes (diet or physical activity) for 3 to 6 months are described. Changes in anthropometric parameters, symptoms, clinical findings and the thickness of superficial adipose tissue measured by ultrasound were evaluated. Results: Treatment with exenatide, whether combined with a change in diet or physical activity, resulted in a reduction in the characteristic symptoms of lipedema, in pain evoked by pinching the adipose tissue fold and in the thickness of subcutaneous adipose tissue at the levels of the lower limbs, abdomen and upper limbs. In four out of five cases, a reduction in body weight was observed, particularly during the first three months of treatment and in cases with greater metabolic impairment. Clinical, instrumental and subjective improvements were also observed in cases where there was no reduction in body weight and in patients who had previously undergone lower limb liposuction. Conclusions: The improvement in symptoms and clinical signs of lipedema, in addition to the reduction in adipose tissue in patients with lipedema and insulin resistance with exenatide, suggests a novel pharmacological approach to the disease, which can be combined with other conservative and surgical treatments to promote weight reduction. These results also highlight the association of this disease with metabolic alterations and the fundamental role of an accurate diagnosis followed by the treatment of comorbidities and excess weight in these patients.<\/jats:p>","DOI":"10.3390\/clinpract15070128","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:58:23Z","timestamp":1751878703000},"page":"128","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with Exenatide"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2024-4607","authenticated-orcid":false,"given":"Laura","family":"Patton","sequence":"first","affiliation":[{"name":"Endocrinology and Lymphology Clinic, 38096 Vallelaghi, TN, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Reverdito","sequence":"additional","affiliation":[{"name":"Physiotherapy Clinic, 10138 Torino, TO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bellucci","sequence":"additional","affiliation":[{"name":"Nutrition Clinic, 38066 Riva del Garda, TN, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Bortolon","sequence":"additional","affiliation":[{"name":"Rehabilitation Unit and Lymphology Clinic, Institute San Gregorio, 31049 Valdobbiadene, TV, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Macrelli","sequence":"additional","affiliation":[{"name":"Physiotherapy Clinic, 47039 Savignano sul Rubicone, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ricolfi","sequence":"additional","affiliation":[{"name":"Endocrinology and Lymphology Clinic, 38096 Vallelaghi, TN, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/02683555211015887","article-title":"Standard of care for lipedema in the United States","volume":"36","author":"Herbst","year":"2021","journal-title":"Phlebology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Patton, L., Ricolfi, L., Bortolon, M., Gabriele, G., Zolesio, P., Cione, E., and Cannataro, R. (2024). Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031599"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin Resistance: From Mechanisms to Therapeutic Strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Janssen, J.A.M.J.L. (2021). Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157797"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ahmed, B., Sultana, R., and Greene, M.W. (2021). Adipose tissue and insulin resistance in obese. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111315"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00211","article-title":"Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease","volume":"39","author":"Smith","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-021-09708-3","article-title":"Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review","volume":"23","author":"Camastra","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.metop.2019.100015","article-title":"Obesity-induced inflammation and insulin resistance: A mini-review on T-cells","volume":"3","author":"Nyambuya","year":"2019","journal-title":"Metabol Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000515381","article-title":"European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis","volume":"14","author":"Muscogiuri","year":"2021","journal-title":"Obes. Facts"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40618-019-01061-2","article-title":"Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: Systematic review and consensus statement from the Italian Society of Endocrinology (SIE)","volume":"42","author":"Caprio","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Paoli, A., Bianco, A., Moro, T., Mota, J.F., and Coelho-Ravagnani, C.F. (2023). The Effects of Ketogenic Diet on Insulin Sensitivity and Weight Loss, Which Came First: The Chicken or the Egg?. Nutrients, 15.","DOI":"10.3390\/nu15143120"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Napole\u00e3o, A., Fernandes, L., Miranda, C., and Marum, A.P. (2021). Effects of Calorie Restriction on Health Span and Insulin Resistance: Classic Calorie Restriction Diet vs. Ketosis-Inducing Diet. Nutrients, 13.","DOI":"10.20944\/preprints202103.0571.v3"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12967-020-02277-0","article-title":"Effects of a ketogenic diet in overweight women with polycystic ovary syndrome","volume":"18","author":"Paoli","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"m4743","DOI":"10.1136\/bmj.m4743","article-title":"Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: Systematic review and meta-analysis of published and unpublished randomized trial data","volume":"372","author":"Goldenberg","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Shu, Y., Wu, X., Wang, J., Ma, X., Li, H., and Xiang, Y. (2022). Associations of Dietary Inflammatory Index With Prediabetes and Insulin Resistance. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.820932"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13679-023-00536-x","article-title":"Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema?","volume":"12","author":"Verde","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cannataro, R., Michelini, S., Ricolfi, L., Caroleo, M.C., Gallelli, L., De Sarro, G., Onorato, A., and Cione, E. (2021). Management of Lipedema with Ketogenic Diet: 22-Month Follow-Up. Life, 11.","DOI":"10.3390\/life11121402"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lundanes, J., G\u00e5rseth, M., Taylor, S., Crescenzi, R., Pridmore, M., Wagnild, R., Hyldmo, \u00c5.A., Martins, C., and Nymo, S. (2024). The effect of a low-carbohydrate diet on subcutaneous adipose tissue in females with lipedema. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1484612"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/EJE-13-0585","article-title":"Therapy in endocrine disease: Treatment of hirsutism in the polycystic ovary syndrome","volume":"170","author":"Pasquali","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: Results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: An overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-154-10-201105170-00007","article-title":"Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: A network meta-analysis","volume":"154","author":"Gross","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e001986","DOI":"10.1136\/bmjopen-2012-001986","article-title":"Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: Systematic review and meta-analysis","volume":"3","author":"Robinson","year":"2013","journal-title":"BMJ Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.28827","article-title":"Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study","volume":"64","author":"Gastaldelli","year":"2016","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/dom.12836","article-title":"Effect of exenatide on postprandial glucose fluxes, lipolysis, and \u00df-cell function in non-diabetic, morbidly obese patients","volume":"19","author":"Camastra","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): A potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul. Pept."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1210\/jc.2002-021545","article-title":"Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes","volume":"88","author":"Kolterman","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/diacare.26.8.2370","article-title":"Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and\/or sulfonylurea treatment in patients with type 2 diabetes","volume":"26","author":"Fineman","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20420188231222367","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-016-1190-4","article-title":"Exendin-4 protects HUVECs from tunicamycin-induced apoptosis via inhibiting the IRE1a\/JNK\/caspase-3 pathway","volume":"55","author":"Wu","year":"2017","journal-title":"Endocrine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/dia.2010.0048","article-title":"Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus","volume":"13","author":"Wu","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide exerts a potent antiinflammatory effect","volume":"97","author":"Chaudhuri","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3094642","DOI":"10.1155\/2016\/3094642","article-title":"Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Poojari, A., Dev, K., and Rabiee, A. (2022). Lipedema: Insights into Morphology, Pathophysiology, and Challenges. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123081"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ricolfi, L., Reverdito, V., Gabriele, G., Bortolon, M., Macherelli, I., Haag, P., De Santis, N., Guerriero, M., and Patton, L. (2024). Micromassage Compression Leggings Associated with Physical Exercise: Pilot Study and Example of Evaluation of the Clinical and Instrumental Effectiveness of Conservative Treatment in Lipedema. Life, 14.","DOI":"10.3390\/life14070854"},{"key":"ref_37","unstructured":"Lontok, E., Briggs, L., Donlan, M., Kim, Y., Mosley, E., Riley, E.A.U., and Stevens, M. (2017). Lipedema: A Giving Smarter Guide, Milken Institute Center."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2006-924233","article-title":"Insulin sensitivity indices: A proposal of cut-off points for simple identification of insulin-resistant subjects","volume":"114","author":"Radikova","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/humrep\/dex308","article-title":"Insulin resistance in a large cohort of women with polycystic ovary syndrome: A comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes","volume":"32","author":"Tosi","year":"2017","journal-title":"Hum. Reprod."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(16)30328-X","article-title":"The need for international consensus on prediabetes","volume":"5","author":"Makaroff","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_43","unstructured":"Societ\u00e0 Italiana di Diabetologia (2025, January 17). Standard Italiani per la cura del Diabete Mellito 2018. Available online: http:\/\/aemmedi.it\/standard-di-cura\/."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2018). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care, 41, S13\u2013S27.","DOI":"10.2337\/dc18-S002"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: A review of three commonly used pain rating scales","volume":"14","author":"Williamson","year":"2005","journal-title":"J. Clin. Nurs."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1079\/BJN19740060","article-title":"Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years","volume":"32","author":"Durnin","year":"1974","journal-title":"Br. J. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/ajcn\/34.11.2540","article-title":"New norms of upper limb fat and muscle areas for assessment of nutritional status","volume":"34","author":"Frisancho","year":"1981","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e14364","DOI":"10.1111\/dth.14364","article-title":"Cause and management of lipedema-associated pain","volume":"34","author":"Aksoy","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Jandali, Z., Jiga, L.P., and Campisi, C. (2022). Lipedema: A Practical Guidebook, Springer International Publishing.","DOI":"10.1007\/978-3-030-86717-1"},{"key":"ref_50","unstructured":"Gorczyca, R., Filip, R., and Walczak, E. (2013). Psychological aspects of pain. Ann. Agric. Environ. Med., 23\u201327."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/11585880-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing","volume":"50","author":"Fineman","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: A randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.70252\/ASAQ8961","article-title":"Consequences of Weight Cycling: An Increase in Disease Risk?","volume":"2","author":"Strohacker","year":"2009","journal-title":"Int. J. Exerc. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41366-024-01542-2","article-title":"The metabolic consequences of \u2018yo-yo\u2019 dieting are markedly influenced by genetic diversity","volume":"48","author":"Thillainadesan","year":"2024","journal-title":"Int. J. Obes."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e3553","DOI":"10.1097\/GOX.0000000000003553","article-title":"Survey Outcomes of Lipedema Reduction Surgery in the United States","volume":"9","author":"Herbst","year":"2021","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_56","first-page":"APCTM-181","article-title":"Preliminary Outcomes of Multimodal Conservative Therapy in Lipedema","volume":"2023","author":"Ricolfi","year":"2023","journal-title":"Adv. Nutr. Food Sci."}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/7\/128\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:05:51Z","timestamp":1760033151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/7\/128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["clinpract15070128"],"URL":"https:\/\/doi.org\/10.3390\/clinpract15070128","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}